株式会社リボルナバイオサイエンス
Fujisawa, JP · 2 known investors
Reborna Biosciences is a Japanese biotech company that researches and develops RNA-targeting small-molecule drugs for hereditary rare diseases. Founded in 2018, it operates from the Shonan iPark research campus.
Founders & leadership
KF
Koji FujiRepresentative Director
YO
Yukimi OdaDirector, CFO
Investors · 2
Frequently asked questions
- What does 株式会社リボルナバイオサイエンス do?
- Reborna Biosciences is a Japanese biotech company that researches and develops RNA-targeting small-molecule drugs for hereditary rare diseases. Founded in 2018, it operates from the Shonan iPark research campus.
- Who are 株式会社リボルナバイオサイエンス's investors?
- 株式会社リボルナバイオサイエンス's investors include Angel Bridge Co.,Ltd., UntroD Capital.
- Where is 株式会社リボルナバイオサイエンス headquartered?
- 株式会社リボルナバイオサイエンス is headquartered in Fujisawa, JP.